CRISPR Therapeutics

Is anyone taking the world’s priciest drugs?
Pharma Voice
Fri, 08/30/24 - 11:28 am
drug prices
gene therapy
CRISPR Therapeutics
Vertex Pharmaceuticals
Sarepta Therapeutics
FDA awarded record number of review designations to CRISPR drugs in 2023
Biopharma Reporter
Tue, 02/6/24 - 09:16 am
CRISPR
FDA
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool
Wed, 01/24/24 - 10:54 am
CRISPR Therapeutics
gene editing
CRISPR
What’s Next for CRISPR?
BioSpace
Tue, 01/23/24 - 06:00 pm
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
Could Editas Medicine Become the Next CRISPR Therapeutics?
Motley Fool
Sun, 01/21/24 - 05:01 pm
Editas Medicine
gene editing
CRISPR Therapeutics
FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia
BioPharma Dive
Wed, 01/17/24 - 09:34 am
Vertex Pharmaceuticals
CRISPR Therapeutics
Casgevy
beta thalassemia
FDA
Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval
Clinical Trials Arena
Wed, 01/17/24 - 09:30 am
CRISPR
gene editing
clinical trials
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
EdiGene
Shanghai Vitalgen BioPharma
Regeneron
Vor Biopharma
5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
FDA
Iovance Biotherapeutics
melanoma
lifileucel
Minerva Neurosciences
schizophrenia
roluperidone
Viatris
Mapi Pharma
MS
multiple sclerosis
GA Depot
Madrigal Pharmaceuticals
NASH
resmetirom
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
beta thalassemia
CRISPR eyes autoimmune disease in revamp of cell therapy plans
BioPharma Dive
Tue, 12/5/23 - 11:38 am
CRISPR Therapeutics
cell therapy
autoimmune disease
cancer
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
Nature
Fri, 11/17/23 - 10:05 am
UK
CRISPR
gene editing
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
BioSpace
Thu, 11/16/23 - 10:21 am
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
UK
Casgevy
beta thalassemia
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
BioSpace
Mon, 11/13/23 - 11:48 am
CRISPR
gene therapy
cell therapy
sickle cell disease
exa-cel
Vertex Pharmaceuticals
CRISPR Therapeutics
Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA
Forbes
Thu, 11/2/23 - 05:07 pm
sickle cell disease
gene therapy
lovo-cel
exa-cel
Vertex Pharmaceutical
CRISPR Therapeutics
Bluebird Bio
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
Yahoo/Reuters
Tue, 10/31/23 - 09:23 pm
Vertex Pharmaceuticals
CRISPR Therapeutics
FDA
gene therapy
exa-cel
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
Motley Fool
Sun, 07/23/23 - 12:28 pm
cell therapy
Caribou Biosciences
CRISPR Therapeutics
U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million
Reuters
Fri, 07/14/23 - 10:07 am
ICER
gene therapy
Vertex Pharmaceuticals
CRISPR Therapeutics
Bluebird Bio
drug pricing
sickle cell disease
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
SAGE Therapeutics
zuranolone
postpartum depression
major depressive disorder
Roche
Tecentriq
non-small cell lung cancer
CRISPR Therapeutics
Bluebird Bio
lovo-cel
exa-cel
BrainStorm Cell Therapeutics
NurOwn
Gene Editing Race Between Editas and Vertex, CRISPR Heats Up
BioSpace
Mon, 06/12/23 - 09:58 am
gene editing
Editas Medicine
Vertex Pharmaceuticals
CRISPR Therapeutics
EDIT-301
sickle cell disease
beta thalassemia
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Fierce Biotech
Fri, 06/9/23 - 10:07 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
FDA
sickle cell disease
beta thalassemia

Pages